Breaking News, Financial News

Moderna 1Q Results Reflect Waning Covid Vax Demand

Product sales in the quarter were down of 69% to $1.8 billion reflecting a drop in COVID-19 vaccine sales.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Moderna 1Q Revenues: $1.9 billion (revenue was $6.1 billion 1Q22) 1Q Earnings: $79 million (earnings were $3.7 billion 1Q22) Comments: Results reflect a decrease in sales of the Company’s COVID-19 vaccines. Product sales in the quarter were $1.8 billion, down of 69%. COVID-19 vaccine sales to Europe were $0.6 billion and sales to the rest of the world were $1.3 billion in the quarter. The total of $1.8 billion in sales represents the vast majority of the projected $2 billion in sales fr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters